Podcasts about Igi

W dzisiejszym magazynie sportowym: srebrny medal Igi Świątek w rozgrywkach mixta tenisowego turnieju US Open, dramatyczna próba przepłynięcie Bałtyku przez polską pływaczkę, kolejne złote medale dla Polski w zawodach World Games.

W dzisiejszym przeglądzie sportowym: zwycięstwo, awans i skandal na meczu Raków Częstochowa. Trzeci z rzędu awans Igi Świątek do półfinału turnieju w Cincinnati, niesamowite rekordy Polaków w zawodach World Games rozgrywanych w Chinach.

Redaktor naczelny portalu tenisklub.pl naświetla świat tenisa. Omawia w szczególności obecną formę i ostatnie mecze Igi Świątek, a także zapowiada nadchodzący US Open. Rozmawia Grzegorz Milko.

Z czego wynika obecna kondycja polskiego sportu? Jakie najpilniejsze wyzwania stoją przed polskimi komitetami i organizacjami sportowymi oraz jakie pomysły na usprawnienie związanego z nimi systemu leżą na stole? O tym rozmawialiśmy podczas sierpniowej Premiery Pisma.Narzekanie na wyniki polskich sportowców i największe sportowe organizacje stało się już niemal naszą oddzielną narodową dyscypliną. Dowcipy o polskiej kadrze piłki nożnej czy klasyfikacji polskich zawodników w rozgrywkach igrzysk olimpijskich zdają się przyćmiewać sukcesy. Dlaczego zatem w niektórych obszarach zwycięstwa przychodzą nam łatwiej niż w innych? Z czego wynika obecna kondycja polskiego sportu? Jakie najpilniejsze wyzwania stoją przed polskimi komitetami i organizacjami sportowymi oraz jakie pomysły na usprawnienie związanego z nimi systemu leżą na stole? O tym rozmawialiśmy podczas sierpniowej Premiery Pisma.W dyskusji wzięli udział:Daria Abramowicz – psycholożka sportowa posiadająca ponad 25-letnie doświadczenie w tej dziedzinie, także jako zawodniczka i trenerka. Absolwentka Uniwersytetu SWPS w Warszawie. Pracuje w obszarze performance psychology we wszystkich sektorach, związanych między innymi z biznesem, kulturą czy edukacją. Najwięcej uwagi od lat poświęca pracy ze sportowcami, z trenerami oraz rodzicami zawodników w różnym wieku, zarówno w dyscyplinach indywidualnych, jak i zespołowych. Odpowiada za przygotowanie mentalne w sztabie szkoleniowym Igi Świątek. Współpracuje także z Aleksandrą Mirosław i Ewą Pajor. Prowadzi projekty edukacyjne, wykłady i szkolenia zakładające zwiększanie świadomości społecznej w zakresie ważnej roli psychologii w środowiskach high performance.Łukasz Smolarow – trener piłkarski z licencją UEFA Pro, dyrektor sportowy. Pracował w Polonii Warszawa, Jagiellonii Białystok, KGHM Zagłębie Lubin, Lechii Gdańsk, ŁKS-ie Łódź. Zdobywca Pucharu i Superpucharu Polski oraz dwukrotnie 3. miejsca w Ekstraklasie. Współautor podręcznika dla trenerów Przygotowanie psychologiczne. Narodowy Model Gry (2020), publikował w „Trenerze” i „Asystencie Trenera”, „Piśmie” oraz Dwutygodniku. Absolwent Instytutu Kultury Polskiej Uniwersytetu Warszawskiego.Michał Okoński – dziennikarz „Tygodnika Powszechnego”. Autor książek Futbol jest okrutny, Światło bramki i Stałe fragmenty, laureat Grand Press w kategorii publicystyka (2023) i Nagrody Mariusza Waltera w kategorii sport w mediach (2023), dwukrotnie nominowany do Nagrody im. Bohdana Tomaszewskiego. Ekspert TVP podczas wielkich turniejów piłkarskich.Debatę poprowadziła Zuzanna Kowalczyk, redaktorka prowadząca w „Piśmie”, dziennikarka, kulturoznawczyni, autorka esejów i podcastów. ––Słuchaj więcej materiałów audio w stałej, niższej cenie. Wykup miesięczny dostęp online do „Pisma”. Możesz zrezygnować, kiedy chcesz.https://magazynpismo.pl/prenumerata/miesieczny-dostep-online-audio/

W dzisiejszym magazynie sportowym; kompromitacja Legii Warszawa w piłkarskim Pucharze Europy, awans Igi Świątek do trzeciej rundy w turnieju w Chinctinati, kolejne sukcesy polskich drużyn siatkarskich...

W dzisiejszym magazynie sportowym: dobra passa Igi Świątek, dominacja polskiej siatkówki na międzynarodowych arenach, najlepszy tydzień w historii polskiej piłki klubowej.

W dzisiejszym magazynie sportowym o historycznym zwycięstwie Igi Świątek na Wimbledonie. Tenisistka zapisuje się w historii jako pierwsza Polka z wielkoszlemowym tytułem na londyńskich kortach.

W tym wydaniu: wielka wygrana polskiej tenisistki Igi Świątek na trawiastych kortach Wimbledonu w Londynie; podsumowanie pierwszego tygodnia kontroli granicznych; tegoroczni laureaci nagrody Kolberga dla twórców ludowych; dr Piotr Kajak, wicedyrektor Centrum Języka Polskiego i Kultury Polskiej dla Cudzoziemców UW „Polonicum” o badaniach nad historią nauczania języka polskiego jako obcego. Zapraszamy do słuchania!

Enzo, Igi e Stefano hanno il piacere di ospitare Giorgio Tavecchio, un passato in NFL ed Elf come Kicker a Oakland, Atlanta e altro, per parlarci della sua esperienza, del ruolo del Kicker, della difficoltà di un ruolo così particolare. Tante spiegazioni tecniche per capire meglio il ruolo, una spiegazione della parte psicologica del ruolo. Esperienze ed aneddoti della NFL dalla sua diretta esperienza.In puntata anche il nostro amico Davide Gabino.Una puntata eccezzionale con un ospite di altissimo livello!

Eric Topol (00:05):Hello, it's Eric Topol from Ground Truths, and I've got some really exciting stuff to talk to you about today. And it's about the announcement for a new Center for pediatric CRISPR Cures. And I'm delight to introduce doctors Jennifer Doudna and Priscilla Chan. And so, first let me say this is amazing to see this thing going forward. It's an outgrowth of a New England Journal paper and monumental report on CRISPR in May. [See the below post for more context]Let me introduce first, Dr. Doudna. Jennifer is the Li Ka Shing Chancellor's Chair and a Professor in the departments of chemistry and of molecular and cell biology at the University of California Berkeley. She's also the subject of this book, one of my favorite books of all time, the Code Breaker. And as you know, the 2020 Nobel Prize laureate for her work in CRISPR-Cas9 genome editing, and she founded the Innovative Genomics Institute (IGI) back 10 years ago. So Jennifer, welcome.Jennifer Doudna (01:08):Thank you, Eric. Great to be here.Eric Topol (01:10):And now Dr. Priscilla Chan, who is the co-founder of the Chan Zuckerberg Initiative (CZI) that also was started back in 2015. So here we are, a decade later, these two leaders. She is a pediatrician having trained at UCSF and is committed to the initiative which has as its mission statement, “to make it possible to cure, prevent, and manage all diseases in this century.” So today we're going to talk about a step closer to that. Welcome, Priscilla.Priscilla Chan (01:44):Thank you. Thanks for having me.Eric Topol (01:46):Alright, so I thought we'd start off by, how did you two get together? Have you known each other for over this past decade since you both got all your things going?Jennifer Doudna (01:56):Yes, we have. We've known each other for a while. And of course, I've admired the progress at the CZI on fundamental science. I was an advisor very early on and I think actually that's how we got to know each other. Right, Priscilla?Priscilla Chan (02:11):Yeah, that's right. We got to know each other then. And we've been crisscrossing paths. And I personally remember the day you won the Nobel Prize. It was in the heart of the pandemic and a lot of celebrations were happening over Zoom. And I grabbed my then 5-year-old and got onto the UCSF celebration and I was like, look, this is happening. And it was really cool for me and for my daughter.Eric Topol (02:46):Well, it's pretty remarkable convergence leading up to today's announcement, but I know Priscilla, that you've been active in this rare disease space, you've had at CZI a Rare As One Project. Maybe you could tell us a bit about that.Priscilla Chan (03:01):Yeah, so at CZI, we work on basic science research, and I think that often surprises people because they know that I'm a pediatrician. And so, they often think, oh, you must work in healthcare or healthcare delivery. And we've actually chosen very intentionally to work in basic science research. In part because my training as a pediatrician at UCSF. As you both know, UCSF is a tertiary coronary care center where we see very unusual and rare cases of pediatric presentations. And it was there where I learned how little we knew about rare diseases and diseases in general and how powerful patients were. And that research was the pipeline for hope and for new discoveries for these families that often otherwise don't have very much access to treatments or cures. They have a PDF that maybe describes what their child has. And so, I decided to invest in basic science through CZI, but always saw the power of bringing rare disease patient cohorts. One, because if you've ever met a parent of a child with rare disease, they are a force to be reckoned with. Two, they can make research so much better due to their insights as patients and patient advocates. And I think they close the distance between basic science and impact in patients. And so, we've been working on that since 2019 and has been a passion of ours.Eric Topol (04:40):Wow, that's great. Now Jennifer, this IGI that you founded a decade ago, it's doing all kinds of things that are even well beyond rare diseases. We recently spoke, I know on Ground Truths about things as diverse as editing the gut microbiome in asthma and potentially someday Alzheimer's. But here you were very much involved at IGI with the baby KJ Muldoon. Maybe you could take us through this because this is such an extraordinary advance in the whole CRISPR Cures story.Jennifer Doudna (05:18):Yes, Eric. It's a very exciting story and we're very, very proud of the teamwork that went into making it possible to cure baby KJ of his very rare disease. And in brief, the story began back in August of last year when he was born with a metabolic disorder that prevented him from digesting protein, it's called a urea cycle disorder and rare, but extremely severe. And to the point where he was in the ICU and facing a very, very difficult prognosis. And so, fortunately his clinical team at Children's Hospital of Philadelphia (CHOP) reached out to Fyodor Urnov, who is the Director of Translational Medicine at the IGI here in the Bay Area. They teamed up and realized that they could quickly diagnose that child because we had an IRB approved here at the IGI that allowed us to collect patient samples and do diagnosis. So that was done.Jennifer Doudna (06:26):We created an off-the-shelf CRISPR therapy that would be targeted to the exact mutation that caused that young boy's disease. And then we worked with the FDA in Washington to make sure that we could very safely proceed with testing of that therapy initially in the lab and then ultimately in two different animal models. And then we opened a clinical trial that allowed that boy to be enrolled with, of course his parents' approval and for him to be dosed and the result was spectacular. And in fact, he was released from the hospital recently as a happy, healthy child, gaining lots of weight and looking very chunky. So it's really exciting.Eric Topol (07:16):It's so amazing. I don't think people necessarily grasp this. This timeline [see above] that we'll post with this is just mind boggling how you could, as you said Jennifer, in about six months to go from the birth and sequencing through cell specific cultures with the genome mutations through multiple experimental models with non-human primates even, looking at off-target effects, through the multiple FDA reviews and then dosing, cumulatively three dosing to save this baby's life. It really just amazing. Now that is a template. And before we go to this new Center, I just wanted to also mention not just the timeline of compression, which is unimaginable and the partnership that you've had at IGI with I guess Danaher to help manufacture, which is just another part of the story. But also the fact that you're not just even with CRISPR 1.0 as being used in approvals previously for sickle cell and β-thalassemia, but now we're talking about base editing in vivo in the body using mRNA delivery. So maybe you could comment on that, Jennifer.Jennifer Doudna (08:38):Yeah, very good point. So yeah, we used a version of CRISPR that was created by David Liu at the Broad Institute and published and available. And so, it was possible to create that, again, targeted to the exact mutation that caused baby KJ's disease. And fortunately, there was also an off-the-shelf way to deliver it because we had access to lipid nanoparticles that were developed for other purposes including vaccinations. And the type of disease that KJ suffered from is one that is treatable by editing cells in the liver, which is where the lipid nanoparticle naturally goes. So there were definitely some serendipity here, but it was amazing how all of these pieces were available. We just had to pull them together to create this therapy.Eric Topol (09:30):Yeah, no, it is amazing. So that I think is a great substrate for starting a new Center. And so, maybe back to you Priscilla, as to what your vision was when working with Jennifer and IGI to go through with this.Priscilla Chan (09:45):I think the thing that's incredibly exciting, you mentioned that at CZI our mission is to cure, prevent, and manage all disease. And when we talked about this 10 years ago, it felt like this far off idea, but every day it seems closer and closer. And I think the part that's super exciting about this is the direct connection between the basic science that's happening in CRISPR and the molecular and down to the nucleotide understanding of these mutations and the ability to correct them. And I think many of us, our imaginations have included this possibility, but it's very exciting that it has happened with baby KJ and CHOP. And we need to be able to do the work to understand how we can treat more patients this way, how to understand the obstacles, unblock them, streamline the process, bring down the cost, so that we better understand this pathway for treatment, as well as to increasingly democratize access to this type of platform. And so, our hope is to be able to do that. Take the work and inspiration that IGI and the team at CHOP have done and continue to push forward and to look at more cases, look at more organ systems. We're going to be looking in addition to the liver, at the bone marrow and the immune system.Priscilla Chan (11:17):And to be able to really work through more of the steps so that we can bring this to more families and patients.Eric Topol (11:30):Yeah, well it's pretty remarkable because here you have incurable ultra-rare diseases. If you can help these babies, just think of what this could do in a much broader context. I mean there a lot of common diseases have their roots with some of these very rare ones. So how do you see going forward, Jennifer, as to where you UC Berkeley, Gladstone, UCSF. I'm envious of you all up there in Northern California I have to say, will pull this off. How will you get the first similar case to KJ Muldoon going forward?Jennifer Doudna (12:13):Right. Well, IGI is a joint institute, as you probably know, Eric. So we were founded 10 years ago as a joint institute between UC Berkeley and UCSF. And now we have a third campus partner, UC Davis and we have the Gladstone Institute. So we've got an extraordinary group of clinicians and researchers that are coming together for this project and the Center to make it a success. We are building a clinical team at UCSF. We have several extraordinary leaders including Jennifer Puck and Chris Dvorak, and they are both going to be involved in identifying patients that could be enrolled in this program based on their diagnosis. And we will have a clinical advisory group that will help with that as well. So we'll be vetting patients probably right after we announce this, we're going to be looking to start enrolling people who might need this type of help.Eric Topol (13:18):Do you think it's possible to go any faster right now than the six months that it took for KJ?Jennifer Doudna (13:26):I think it could be. And here's the reason. There's a very interesting possibility that because of the type of technology that we're talking about with CRISPR, which fundamentally, and you and I have talked about this previously on your other podcast. But we've talked about the fact that it's a programmable technology and that means that we can change one aspect of it, one piece of it, which is a piece of a molecule called RNA that's able to direct CRISPR to the right sequence where we want to do editing and not change anything else about it. The protein, the CRISPR protein stays the same, the delivery vehicle stays the same, everything else stays the same. And so, we're working right now with FDA to get a platform designation for CRISPR that might allow streamlining of the testing process in some cases. So it'll obviously come down to the details of the disease, but we're hopeful that in the end it will be possible. And Priscilla and I have talked about this too, that as AI continues to advance and we get more and more information about rare diseases, we'll be able to predict accurately the effects of editing. And so, in some cases in the future it may be possible to streamline the testing process even further safely.Eric Topol (14:51):And I also would note, as you both know, well this administration is really keen on genome editing and they've had a joint announcement regarding their support. And in my discussions with the FDA commissioner, this is something they are very excited about. So the timing of the new Center for pediatric CRISPR Cures is aligned with the current administration, which is good to see. It's not always the case. Now going back, Priscilla, to your point that not just for the liver because delivery has been an issue of course, and we're going to try to get after a lot of these really rare diseases, it's going to go beyond there. So this is also an exciting new dimension of the Center, as you said, to go after the bone marrow for hematopoietic cells, perhaps other organs as well.Priscilla Chan (15:42):I mean what the expertise and feasibility, the immune system is going to be the next target. Jennifer Puck has been a pioneer in this work. She's the one who designed the newborn screen that will be the tool that picks up these patients as they are born. And I think the thing that's tremendous is the immune system, first of all is active in many, many diseases, not just these cases of children born with partial or absence of immune systems. And the course right now that these babies are left with is complete isolation and then a very long and arduous course of a bone marrow transplant with high morbidity and mortality. And even if after the transplant you have complications like graft versus host and immunosuppression. And so, the idea of being able to very specifically and with less the conditioning and morbidity and mortality of the treatment, being able to address this is incredible. And the implications for other diseases like blood cancers or other hematopoietic diseases, that's incredible. And that actually has an incredibly broad base of patients that can benefit from the learnings from these babies with severe combined immunodeficiencies.Eric Topol (17:10):Yeah, I think that goes back to a point earlier maybe to amplify in that previous CRISPR generation, it required outside the body work and it was extremely laborious and time consuming and obviously added much more to the expense because of hospitalization time. This is different. This is basically doing this inside the affected patient's body. And that is one of the biggest reasons why this is a big step forward and why we're so fortunate that your Center is moving forward. Maybe before we wrap up, you might want to comment, Jennifer on how you were able to bring in to build this platform, the manufacturing arm of it, because that seems to be yet another dimension that's helpful.Jennifer Doudna (18:01):Indeed, yes. And we were again fortunate with timing because you mentioned briefly that the IGI had set up a program with the Danaher Corporation back in January of last year. We call it our Beacon project. And it's focused on rare disease. And it's a really interesting kind of a unique partnership because Danaher is a manufacturing conglomerate. So they have companies that make molecules, they make proteins, they make RNA molecules, they make delivery molecules. And so, they were excited to be involved with us because they want to be a provider of these types of therapies in the future. And they can see the future of CRISPR is very exciting. It's expanding, growing area. And so, that agreement was in place already when the baby KJ case came to our attention. And so, what we're hoping to do with Danaher is again, work with them and their scientists to continue to ask, how can we reduce the cost of these therapies by reducing the cost of the molecules that are necessary, how to make them efficiently. We already, it's very interesting, Fyodor Urnov has toured their plant in North Dakota recently, and he found in talking to their engineers, there are a number of things that we can already see will be possible to do that are going to make the process of manufacturing these molecules faster and cheaper by a lot.Eric Topol (19:28):Wow.Jennifer Doudna (19:28):So it's a win-win for everybody. And so, we're really excited to do that in the context of this new Center.Eric Topol (19:36):Oh, that's phenomenal because some of these disorders you don't have that much time to work with before they could be brain or organ or vital tissue damage. So that's great to hear that. What you built here is the significance of it can't be under emphasized, I'll say because we have this May report of baby KJ, which could have been a one-off and it could have been years before we saw another cure of an ultra-rare disorder. And what you're doing here is insurance against that. You're going to have many more cracks at this. And I think this is the excitement about having a new dedicated Center. So just in closing, maybe some remarks from you Priscilla.Priscilla Chan (20:24):I just want to emphasize one point that's really exciting as we talk about these ultra-rare cases that they're often like one in a million. All these learnings actually help maximize the impact of lots of research across the sector that impacts actually everyone's health. And so, our learnings here from these patients that have very significant presentations that really can stand to benefit from any treatment is hopefully paving the way for many, many more of us to be able to live healthier, higher quality lives through basic science.Eric Topol (21:13):And over to you, Jennifer.Jennifer Doudna (21:15):Couldn't agree more. It's a really interesting moment. I think what we hope we are, is we're at sort of an inflection point where, as I mentioned earlier, all the pieces are in place to do this kind of therapeutic and we just need a team that will focus on doing it and pulling it together. And also learning from that process so that as Priscilla just said, we are ultimately able to use the same strategy for other diseases and potentially for diseases that affect lots of people. So it's exciting.Eric Topol (21:46):For sure. Now, if I could just sum up, this is now a decade past the origination of your work of CRISPR and how already at the first decade culminated in sickle cell disease treatment and β-thalassemia. Now we're into the second decade of CRISPR. And look what we've seen, something that was unimaginable until it actually happened and was reported just a little over a month ago. Now going back to Priscilla's point, we're talking about thousands of different rare Mendelian genomic disorders, thousands of them. And if you add them all up of rare diseases, we're talking about hundreds of millions of people affected around the world. So this is a foray into something much bigger, no less the fact that some of these rare mutations are shared by common diseases and approaches. So this really big stuff, congratulations to both of you and your organizations, the Innovative Genomics Institute and the Chan Zuckerberg Initiative for taking this on. We'll be following it with very deep interest, thank you.****************************************************Thanks for listening, reading and subscribing to Ground Truths.If you found this interesting PLEASE share it!That makes the work involved in putting these together especially worthwhile.Thanks to Scripps Research, and my producer, Jessica Nguyen, and Sinjun Balabanoff for video/audio support.All content on Ground Truths—its newsletters, analyses, and podcasts, are free, open-access.Paid subscriptions are voluntary and all proceeds from them go to support Scripps Research. They do allow for posting comments and questions, which I do my best to respond to. Please don't hesitate to post comments and give me feedback. Let me know topics that you would like to see covered.Many thanks to those who have contributed—they have greatly helped fund our summer internship programs for the past two years. Get full access to Ground Truths at erictopol.substack.com/subscribe

W dzisiejszym magazynie sportowym m.in. pierwszy finał Igi Świątek w turnieju na kortach trawiastych, sukcesy polskich siatkarzy i siatkarek w Lidze Narodów, Polak zawodowym mistrzem świata w boksie.

Gośćmi Edyty Kowalczyk i Łukasza Kadziewicza będą: Sebastian Świderski, Radosław Majdan, Michał Zawacki, Bartek Ignacik i Aaron Cel. Porozmawiamy o zbliżających się mistrzostwach Europy w piłce nożnej kobiet, o świetnych występach naszych siatkarek i siatkarzy w Lidze Narodów, o ostatnim sprawdzianie Igi Świątek przed Wimbledonem oraz o tryumfie Legii Warszawa, ale nie tej piłkarskiej, a koszykarskiej.

Mimo wszystko, trzeba podkreślić, że oba tegoroczne turnieje Wielkiego Szlema to są naprawdę dobre starty Igi Świątek - zwraca uwagę redaktor naczelny portalu Historia Tenisa. 

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates discuss Victoria's recent trip to Paris as a guest of Japanese watchmaker Credor to celebrate the brand's update on a classic Gérald Genta timepiece from 1979. Next, the pair gear up for JCK Las Vegas by highlighting some of the exciting events on their show agenda, from Rob moderating an expert panel on cybercrime and security to Victoria reporting on emerging jewelry trends from the show floor. Other highpoints on the lineup include a keynote speech from Disney's former head of innovation and live performances by Jason Derulo and Snoop Dogg. Sponsored by IGI: igi.org/education

Grandi rinnovi in casa Niners, John Lynch e la proprietà mettono al sicuro 3 pilastri della franchigia: Brock Purdy, George Kittle e Fred Warner!Enzo, Igi e Stefano nel parlano in questo episodio.

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates talk with Marc Bridge, CEO and founder of online jewelry platform At Present. A fifth-generation scion of the Ben Bridge family, Marc describes a life in the industry that began with cleaning jewelry cases as soon as he was tall enough to reach them, included a memorable cross-country trip to deliver homemade cookies to Warren Buffett, and spanned decades as a problem solver for the family firm. He urges the industry to sharpen its storytelling skills in order to deepen consumers' appreciation for gems and explains his role as matchmaker through At Present, connecting jewelry lovers who crave unique pieces with the artisans who create them. Presenting sponsor: IGI (igi.org/education) Sponsor: Nivoda (nivoda.com)

W dzisiejszym magazynie sportowym m.in. o porażce Igi Świątek, która ma katastrofalne skutki dla rankingu WTA! Polka nie będzie już drugą rakietą świata i spadnie na pozycję numer cztery.

W audycji również rzut oka na nieudany występ Igi Świątek w turnieju WTA w Rzymie.

Puntata di analisi del draft 2025 dei San Francisco 49ers.In studio Enzo, Igi e Stefano. Siamo lieti di aver pututo ospitare, anche se da remoto, il fine conoscitore NCAA Oleg Bogdea, penna e voce di: La strada verso il draft, Podcast verso/dopo il draft, Scusate il Collage Football.Su tutte le piattaforme podcast oltre la Live Video di YouTube.

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates explore the ramifications of the staggering rise in gold prices and share a strategy jewelers can use to offer gold at more palatable prices. (Hint: Think vintage.) Next, the conversation turns to tariffs. What's ahead? What's the best way to navigate it? Jewelers learned to pivot during the pandemic, and that agility will help them weather today's volatile times, Rob and Victoria predict. They wrap up the conversation with a preview of what to expect when JCK Las Vegas kicks off in June. Presenting sponsor: IGI (igi.org/education) Sponsor: Nivoda (nivoda.com)

W dzisiejszym magazynie sportowym : finał pucharu Polski w piłce nożnej, ostatnia kolejka australijskiej piłkarskiej A-League oraz dramat Igi Świątek na turnieju w Madrycie...

In this week's episode, JCK editor-in-chief Victoria Gomelsky and news director Rob Bates Victoria discuss highlights from Watches and Wonders, including a Bremont relaunch, new Bulgari pieces, and Rolex's first new collection in 13 years. “Rolex has really thrown down the gauntlet,” with its new Dynapulse escapement, Victoria reports. Next, the pair analyze the effect the U.S. administration's initial tariff announcements had on the jewelry industry (confusion and worry) and offer some perspective on what may lie ahead in a time of rapid change and continuing uncertainty. Presenting sponsor: IGI (igi.org/education) Sponsor: Nivoda (nivoda.com)

Gośćmi Edyty Kowalczyk i Łukasza Kadziewicza w "Misji Sport" będą: Tomasz Wolfke, Łukasz Olkowicz, Wojsław Rysiewski, Tomasz Mańko i Bartosz Huzarski. Wśród tematów m.in. niemoc Igi Świątek w meczach z Jeleną Ostapenko, walka o mistrza Ekstraklasy oraz bój o utrzymanie, a także zbliżająca się gala KSW w Gliwicach. 

W dzisiejszym magazynie sportowym: wygrana Legi w jaskini lwa 2:1 dla Warszawiaków z Chelsea London, Sydney FC odpada w półfinale azjatyckiej ligi mistrzów oraz czarna seria Igi Świątek w konfrontacji z Jeleną Ostapenką.

Gośćmi Aldony Marciniak i Łukasza Kadziewicza będą: Dawid Celt, Andrzej Grzebyk, Jarosław Koliński, Radosław Kietliński i Kamil Wolnicki. Porozmawiamy o weekendowych zmaganiach w Billie Jean King Cup oraz o powrocie Igi Świątek do gry. Zaczyna się przecież granie na kortach ziemnych. Następnie przejdziemy do zbliżającej się gali XTB KSW 105. W walce wieczoru zmierzą się Andrzej Grzebyk i Adrian Bartosiński, a pierwszy z nich będzie w naszym studio. Zastanowimy się także nad tym, czy coś zaskakującego może się jeszcze wydarzyć w rewanżach Ligi Mistrzów, a także o tym, jakiego czwartku spodziewać się w wykonaniu polskich drużyn w Lidze Konferencji Europy.

W dzisiejszym magazynie sportowym: dwie niespodzianki w turnieju tenisowym w Miami-wygrana Magdy Linette z Coco Gauff i przegrana Igi Świątek z zajmującą 140 miejsce 19-łatką z Filipin; polska reprezentacja narodowa w piłce nożnej z kompletem punktów w eliminacjach do mistrzostw świata oraz zwycięstwo Socceroos nad drużyną Chin 2:0 w eliminacyjnym meczu do mistrzostw świata...

Gośćmi Aldony Marciniak i Łukasza Kadziewicza w kolejnym odcinku "Misji Sport" będą Bartek Ignacik, Mateusz Leleń, Kamil Wolnicki i Łukasz Olkowicz. A porozmawiamy o tym, co przetacza się właśnie przez polskie skoki, o echach turnieju w Miami i o tym, jak przebiega współpraca Igi Świątek z Wimem Fisette a także o sytuacji w polskiej Ekstraklasie - czy ktoś jeszcze będzie w stanie zagrozić piłkarzom Marka Papszuna?

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates recap highlights from NYC Jewelry Week, including takeaways from The Plumb Club's Symposium '25 that leaders everywhere can apply to help their businesses succeed. Rob brings listeners up to speed on how the ever-changing tariff news could impact the jewelry industry and shares emerging trends from the diamond market. Finally, Victoria discusses the most-talked-about rumors and reports from the watch world, including acquisitions, major management shifts shaking up the top players, and buzz about a potential new line from Rolex. Sponsored by IGI: igi.org/education

On this week's episode, JCK editor-in-chief Victoria Gomelsky and news director Rob Bates discuss highlights from the colored gem shows in Tucson, where designers were buzzing over Guatemalan jade. Rob updates listeners on big news from De Beers, which sealed a 10-year deal with Botswana and saw its value written down significantly. In other news, one of Signet's largest shareholders has called for a sale of the company. Rob offers insights into the factors driving these headline-making stories. Finally, Victoria reports on the state of the Swiss watch industry as Audemars Piguet marks its 150th anniversary. Sponsored by IGI: igi.org/education

W dzisiejszym magazynie sportowym: awans Igi Świątek do trzeciej rundy tenisowego turnieju Indian Wells, polski napastnik Patryk Klimala zapewnił zwycięstwo Sydney FC w ćwierć finałach azjatyckiej piłkarskiej Ligi Mistrzów oraz polscy sportowcy zdobywają medale w halowych mistrzostwach Europy w lekkiej atletyce...

Victoria Gomelsky and Rob Bates interview John Greene, president and CEO of Lux Bond & Green, a fifth-generation family-owned jewelry store based in Connecticut. John, winner of the 2025 Gem Award for Lifetime Achievement, recounts the story of a 127-year retailing tradition in his family. He also offers insights into noteworthy trends he's seeing on the sales floor. Sponsored by IGI: igi.org

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates discuss LVMH's recent annual Watch Week in New York City. Highlights include Tiffany's dazzling 13-foot Bird on a Rock sculpture, cutting-edge clocks in the shape of cars and grenades from L'Epée, and a mini miracle—a tiny mechanical Bulgari Serpenti watch. Next, Victoria and Rob share some perspective on recent reports about trouble at LVMH and downturns in the Swiss watch market. Finally, the pair honor a jeweler with a heart of gold, the late Harvey Rovinsky of Bernie Robbins. Sponsored by IGI: igi.org

JCK editor-in-chief Victoria Gomelsky and news director Rob Bates interview our first-ever father-daughter guest duo, Richard “Dick” Hughes and Billie Hughes, co-founders of Lotus Gemology, a full-service colored gemstone testing lab based in Bangkok. The pair give listeners an insider's guide to the complex world of colored stones. Why is describing faceted color gemstones “pure hell”? (“It's like trying to describe the wind,” in Dick's words.) How do experts really detect treated stones? Bonus: Find out how you can learn more from these experts in Tucson. Sponsored by IGI: igi.org

Hala Abdallah is a Saudi Arabian content creator, entrepreneur, and global influencer. A graduate of OTIS College of Art and Design in Los Angeles. And jewelry design from IGI she combines her passion for art, design, and fashion through her brand, OFA. Known for her striking style and collaborations with luxury brands, Hala is redefining influencer culture in the Middle East. An adventurous spirit, she's a horse rider, she's a scuba diver, and world traveler who draws inspiration from her own life.  On this episode, Mo and Hala explore wide range of topics, the power of action over perfection, emphasizing how taking risks and embracing failure drives personal and professional growth. They discuss starting small, iterating, and overcoming the fear of failure, highlighting strategies for cultivating action, balancing preparation with bold decisions, and building confidence to take the first step. 00:00 Intros02:45 Background & Early Life07:30 Finding Passion Through Curiosity12:15 Breaking Barriers18:40 The Role of Fear in Personal Growth23:10 Interpretation & Influence30:05 Transformative Moments in Adulthood35:50 Cultural Narratives40:20 Building Bridges Through Storytelling45:15 Challenges Faced as a Creative50:00 Overcoming Doubt & Embracing Purpose55:40 Listening to Your Inner Voices1:01:20 Spirituality & the Power of Prayer1:05:35 Connection & Community1:10:10 Hala's Favorite Creative Mediums1:15:50 Navigating Life's Transitions1:20:30 The Role of Mentors1:25:45 Childhood Dreams1:30:15 Moments of Self-Discovery1:35:00 Overcoming Loss1:40:15 Childhood Dreams & Telepathic Connections1:47:20 Self-Reflection1:54:30 Designing a Life of Gratitude

Victoria Gomelsky and Rob Bates discuss recent holiday sales results and weigh in on what 2025 may bring for jewelers as a new administration takes office, tariffs loom on the horizon, and gold prices remain high. Also discussed is the latest news from De Beers after a less-than-banner year, Rob's upcoming mystery novel (the final installment of his Diamond District series), and how factors such as Pantone's Color of the Year and the Year of the Snake may—or may not—impact jewelry design. Sponsored by IGI: igi.org

Dense fog alert: Zero visibility in parts of Delhi NCR as AQI drops; Flight departures hit at IGI, Pune woman murdered by colleague at office parking lot; viral video shows mute onlookers, California wildfires: ‘Apocalyptic' fires continue, over 4,000 structures gone; toll likely to rise, All We Imagine As Light wins big at NYFCC awards, Rohit Sharma's post-Champions Trophy retirement plan mooted by his ex-IPL captain

W podsumowaniu roku Sport in brief: Igrzyska olimpijskie w Paryżu EURO 2024 Trudny rok Igi Świątek Chcesz mieć najważniejsze wiadomości o gospodarce, nowych technologiach, sporcie, marketingu i zmianach na świecie zebrane w jednym miejscu? Zasubskrybuj kanał Jarosław Kuźniar in Brief ► https://bit.ly/J-Kuzniar-inBrief Uwielbiasz podcasty? Słuchać, tworzyć, produkować, wszystko naraz? Zapisz się na newsletter Voice House o świecie podcastingu ► https://bit.ly/newsletterVoiceHouse Masz pomysł na rozmowę? Napisz ► office@voicehouse.co

W dzisiejszym magazynie sportowym: awans polskich drużyn piłkarskich do dalszej fazy rozgrywek Ligi Konferencji Europy, sensacyjne wyniki w australijskiej piłkarskiej A-League, oraz trzy nagrody dla Igi Świątek na zakończenie sezonu tenisowego...

Streak negativa interrotta con San Francisco, ne parliamo insime a Igi si Italian Red&Gold

W najnowszym odcinku Sport in Brief: Wim Fisette nowym trenerem Igi Świątek Jeremy Sochan zostaje w San Antonio Spurs Robert Lewandowski liderem klasyfikacji strzelców Chcesz mieć najważniejsze wiadomości o gospodarce, nowych technologiach, sporcie, marketingu i zmianach na świecie zebrane w jednym miejscu? Zasubskrybuj kanał Jarosław Kuźniar in Brief ► https://bit.ly/J-Kuzniar-inBrief Uwielbiasz podcasty? Słuchać, tworzyć, produkować, wszystko naraz? Zapisz się na newsletter Voice House o świecie podcastingu ► https://bit.ly/newsletterVoiceHouse Masz pomysł na rozmowę? Napisz ► office@voicehouse.co

W dzisiejszym magazynie sportowym: sensacyjne rozstanie Igi Świątek z trenerem, zaskakujące wygranie polskich drużyn w europejskich pucharach piłkarskich oraz wielki finał w Rugby League dla Penrith Panthers.

SZYBKO, SZYBKO ŻEBY ZDĄŻYĆ!!! Dziś z Patrykiem jako gościem, bo nie ma Igi. Wspominamy nasze czasy dziennikarzenia i to, co było w nich dobre (staramy się nie marudzić ;)). w CJG Patryk mówi o nowej Zeldzie, Dominik o Astro Bocie, a Tomek o komiksie O najntisach, miłości, kobiecości i młodości. Dziękujemy za wsparcie na patronite.pl/niezatapialni!

The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don't. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.

Which trees would you keep if you had to narrow your collection down to three trees? What would you look to acquire if you lost all of your trees?South African bonsai grower Richard Wright has faced these and similar questions more than once since he started working with small trees, and he's found that the experience has given him great focus in life and in bonsai. Learn more about Rich:Bonsai Rich on IGI am Richard Wright (personal website)

Magazyn sportowy w opracowaniu Piotra Pokorskiego, w którym m.in. triumf Igi Świątek na Roland Garros w Paryżu. Ewa Swoboda zdobyła srebrny medal lekkoatletycznych mistrzostw Europy w Rzymie w biegu na 100 metrów. Dobry początek dla polskich piłkarzy ...

Join NAFI: www.nafinet.org Podcast listeners can get a $10 discount to NAFI memberships by using Discount Code: POD49 This episode is sponsored by: Sporty's May is Learn to Fly Month at Sporty's. It's a four-week celebration of learning to fly designed to inspire and help new pilots achieve their aviation goals. In addition to savings on popular pilot gear, Sporty's Media Network will celebrate Learn to Fly Month with articles, videos, webinars and more.  Visit sportys.com/learntoflymonth for more information  ----------------------------------------------------------------------- Earn FAA Wings Credits for Listening: Click Here to take the Wings Quiz Mental health is a critical aspect of our overall well-being, and it is essential for pilots and others in aviation as well. Significant underreporting of mental health conditions is known to be widespread throughout the aviation industry. In this episode, we will review the signs and symptoms of mental illness and explore ways that pilots may self-report any mental health issues they may be experiencing. We will discuss how flight instructors can be alert to the signs and symptoms of mental illness, and we will explain how to remove the stigma that surrounds mental health issues. We will highlight reporting systems that are designed to maintain confidentiality while ensuring that individuals receive the necessary support while taking appropriate measures to ensure flight safety.   Dr. Victor Vogel is a board-certified and fellowship-trained medical oncologist specializing in breast cancer prevention and treatment. He obtained his medical degree from Temple University School of Medicine, completed his residency at Johns Hopkins Bayview Medical Center, and his fellowship in medical oncology at the Johns Hopkins Oncology Center. Dr. Vogel has also served as the National Vice President for Research at the American Cancer Society. A pilot since 1980, Dr. Vogel holds a CFII, AGI, and IGI. He has owned a Beech Sierra and for the past 15 years a Cirrus SR22. He has flown to 40 of the 50 states and serves as a FAASTeam Representative. He is a member of the IFR Magazine Editorial Board. In retirement, Dr. Vogel plans to become a full-time flight instructor and is the founder of Susquehanna STEM to the Skies, an educational foundation that will utilize a full-motion advanced aviation training device to introduce high school youth to aviation as a career opportunity.

Mystery novelist and JCK News Director Rob Bates returns to the show for a seventh time. The show begins with Paul analyzing whether the current diamond market softness is more cyclical or secular in nature. Next, Paul and Rob talk about how the retail segment of the trade is currently viewing lab-grown diamonds and whether a “pivot” back to natural diamonds is in the cards. The two then discuss what they got right and wrong about the evolution of LGD jewelry over the last decade. Next, Paul and Rob dissect a ruling by the U.K.'s Advertising Standards Agency pertaining to LGD producer Skydiamond and they share thoughts on news of for-profit gem-lab IGI reportedly considering a public offering. Finally, the two opine on the watch market and whether they would personally buy a Rolex.   Hosted by: Paul Zimnisky Guest: Rob Bates Guest plug: www.robbatesauthor.com More information on PZDA's State of the Diamond Market report: www.paulzimnisky.com/products   Show contact: paul@paulzimnisky.com or visit www.paulzimnisky.com.   Please note that the contents of this podcast includes anecdotes, observations and opinions. The information should not be considered investment or financial advice. Consult your investment professional before making any investment decisions. Please read full disclosure at: www.paulzimnisky.com.

Join NAFI: www.nafinet.org Podcast listeners can get a $10 discount to NAFI memberships by using Discount Code: POD49 This episode is sponsored by: Avemco Insurance Company Learn more about the NAFI CFI Insurance Plan ------------------------------------------------------------------- Discover the vital knowledge every pilot should possess regarding takeoff rejects. Through insightful explanations and practical examples, this video aims to equip both experienced aviators and aspiring pilots with the necessary skills to make informed decisions during critical moments before takeoff. Philip Mandel earned his Private in 1981 followed by his Instrument rating, Commercial cert, CFI, CFI-I, MEI, AGI, and IGI certs and rating. He has owned airplanes ranging from a C-150 to a Piper Apache and is currently the proud owner of his 10th aeroplane, a Thorp T-18 (no, he didn't build it). Phil is an active flight instructor based at Starks Twin Oaks Airpark, 7S3, Hillsboro OR. He was the FAASTeam Rep of the Year for the Portland, OR FSDO in 2020 and 2021.  

The gut microbiome, which consists of trillions of bacteria, viruses, and fungi, plays a crucial role in our health. However, there is still much to learn about this complex ecosystem. On this episode we talk with experts who tell us where the science is—how much we know, and how much we don't. Two companies, Bloom Science and Seres Therapeutics, are leveraging the microbiome to develop new therapeutics. The potential of the microbiome is vast, and further research and technological advancements will continue to unlock its benefits.Follow us on LinkedIn, X, Facebook and Instagram. Visit us at https://www.bio.org/

In this episode, we're joined by Andrew Brewer to give us some value from his real estate investing adventure, from investing in single-family out-of-state to redevelopment and commercial projects. We'll also cover some of the steps he took to level up his real estate career, the value of having a supportive life partner in business, and the continuous expansion of his company across multiple asset classes. Tune in and never miss this episode!Key Points & Relevant TopicsAndrew's background and his start in real estate navigating different asset classesWhy Andrew decided to invest out of California and choose the Kansas market insteadChallenges of operating and managing properties out-of-stateThe significance of having a support system in real estate investingBuilding a team and partnerships in starting a real estate development businessValuable market insights on Austin and San Antonio, TXThe impact of real estate investing on one's freedom and personal relationshipsResources & LinksApartment Syndication Due Diligence Checklist for Passive InvestorAbout Andrew BrewerAndrew Brewer is a commercial operator and developer who brings years of experience in many facets of real estate to IronGall Investments. He is also the co-founder of Distance 3 Development, a San Antonio-based real estate development and investment firm. Prior to starting IronGall Investments, Andrew had a successful career as a stationary engineer. As an engineer Andrew oversaw operations in high-rise commercial facilities valued individually at over $200M. He successfully completed full building turnarounds of underperforming commercial assets leading to improved operations, lower maintenance costs, and improved resident experiences. In addition to his engineering work, Andrew has acted as a consultant in construction defect litigation lawsuits. He has assisted prosecutors in pursuing judgements in excess of $60M, and overseen commercial reconstruction projects valued individually at over $12m. Andrew formed IronGall Investments in 2017. Backed by Andrew's experience in commercial asset management, construction defect litigation, and commercial reconstruction, IronGall Investments began to sponsor and develop multifamily, townhome, and single-family home communities. Since 2017, IGI has served as the lead sponsor and lead developer on multiple ground up development projects and land subdivision projects comprising hundreds of residential units valued at over 160 million combined. Andrew works tirelessly to keep all of IronGall Investments's projects running smoothly and rigorously evaluates all potential opportunities using IronGall Investments's landmark “Systematic Selection” approach to project evaluation which includes a nuanced analysis of the strengths and weaknesses of each particular project and corresponding market. Get in Touch with AndrewWebsite: IronGall Investments / Distance 3 DevelopmentFacebook: Andrew Brewer / IronGall InvestmentsLinkedIn: Andrew Brewer / IronGall InvestmentsTo Connect With UsPlease visit our website www.bonavestcapital.com and click here to leave a rating and written review!